Abstract
Plasmodium berghei ANKA causes lethal malaria in mice. It is well established that C57BL/6 mice die early with fulminant symptoms including convulsion, whereas BALB/c mice survive this phase and die later of anemia and prostration. Early death in C57BL/6 mice has been considered to result from the adverse effects of inflammatory cytokines. To elucidate the CD4+ T cell responses in early death due to severe malaria, the kinetics of CD4+ T cells were compared by analyzing cell surface markers and the production of cytokines and transcription factors. The results revealed that cytokine production by CD4+ T cells was induced as early as 5 days after infection and the maintenance of higher levels of IL-4 and IL-10 may be associated with the protection of BALB/c mice from early death. These results suggest that parasite control in the early phase of infection may be important for the development of an effective vaccine.
Avoid common mistakes on your manuscript.
Malaria claims more than one million lives every year worldwide (Snow et al. 2005; WHO 1992). Among four species of Plasmodium parasites that cause human malaria, Plasmodium falciparum is by far the most malignant species and causes severe malaria, inducing cerebral symptoms and anemia that often result in death. Previous studies have revealed the complex pathogenesis of malaria, including (1) the adhesion of parasite-infected erythrocytes to endothelial cells that results in micro-thrombi in various organs, causing multiple organ failure (Mackintosh et al. 2004) and (2) the production of various inflammatory cytokines such as IFN-γ, which is produced by Th1, CD8+ T, γδT, and NK cells, and TNF-α and IL-6 that are produced by NK cells and monocytes/macrophages (Armah et al. 2007; Nie et al. 2007; Langhorne et al. 2004).
The murine malaria parasite Plasmodium berghei ANKA causes similar severe disease in mice and has been used as a model of human P. falciparum infection (Yanez et al. 1996; de Kossodo and Grau 1993; Griffith et al. 2007). It is well established that C57BL/6 mice, which show a Th1-biased phenotype, die of severe malaria in the early phase of infection, while BALB/c mice that show a Th2-biased phenotype survive this period and then eventually die of anemia and prostration infection (Yanez et al. 1996; de Kossodo and Grau 1993; Griffith et al. 2007). Because the symptoms in C57BL/6 mice mimic human severe malaria, the immunological responses involving CD4+ T cells were compared in these two strains.
Although excessive production of inflammatory cytokines may lead to early death by cerebral malaria (Nie et al. 2007; Yanez et al. 1996; de Kossodo and Grau 1993; Haque et al. 2001), these cytokines could also protect hosts by promoting the exclusion of parasites in early infection (Perlmann et al. 1998). IFN-γ, a Th1 cytokine, activates macrophages to produce IL-12, oxygen radicals, and carbon monoxide, which have parasiticidal activity. TNF-α activates NF-κB and MAPK to induce the production of inflammatory cytokines including IL-6, which promotes antibody production, B cell proliferation, and T cell differentiation and activation. Antibodies of IgG1 and IgG3 subclasses opsonize macrophages to phagocytoze parasite-infected erythrocytes. On the other hand, regulatory cytokines such as IL-10 and TGF-β may prohibit early death through the suppression of Th1 responses (Nie et al. 2007; Riley et al. 2006). IL-4 produced by Th2 cells is known to promote the exclusion of parasites in late infection (Perlmann et al. 1998).
CD4+ T cells produce various cytokines and play pivotal roles in immune responses (Cruz Cubas et al. 1994). CD4+ T cells are now classified into four subsets: Th1, Th2, Th17, and Treg cells according to the cytokines they produce and the functions they perform (Weaver et al. 2007). Generally, Th1 cells help to protect hosts from bacteria or virus infection, which requires mainly cellular immunity, while Th2 cells help to protect against helminth infection that requires mainly humoral immunity. Th17 cells, which have been characterized recently, play important roles in inflammatory and autoimmune responses (Weaver et al. 2007). At present, there are no reports concerning Th17 responses against malaria parasite infection. CD4+CD25+ regulatory T (Treg) cells (Sakaguchi et al. 1995) suppress host immune responses and promote the proliferation of pathogens leading to persistent infection (Belkaid and Rouse 2005). There are contradictory reports on the roles of Treg cells in malaria, depending on the host and parasite species. Several researchers reported that Treg cells suppress the host immune system and aggravate malaria both in human and mice (Belkaid and Rouse 2005; Walther et al. 2005; Hisaeda et al. 2004; Long et al. 2003). On the other hand, it was also shown that Treg cells protect hosts through suppression of severe inflammation (Seixas and Ostler 2005).
When a mosquito vector bites a vertebrate host, sporozoite stage malaria parasites first proliferate in the liver and then infect red blood cells. It is generally believed that the liver stage parasites do not induce immunological reactions, though some researchers think otherwise (Doolan and Martinez-Alier 2006; Hoffman et al. 1990). Immune responses against sporozoites are mediated by CD8+ T cells, which attack parasitized liver cells. CD4+ T cells help CD8+ T cells through the production of IFN-γ and IL-4.
Although the blood stage parasites play major roles in the pathogenesis of malaria, the lack of MHC on erythrocytes hampers cellular immunity, leaving antibodies as the only functional modality to remove parasites. However, parasites can use antigen variation or mutation to circumvent protection by antibodies. On the other hand, it was shown that cytokine-producing CD4+ T cells are essential to protective immunity (Stephens and Langhorne 2006; Cockburn and Zavala 2007; Langhorne 1994).
Thus, CD4+ T cells a play pivotal role in protection against malaria in innate immunity, antibody production, and cellular immunity by producing various cytokines. However, CD4+ T cell responses in early erythrocytic stage parasites have not been well studied because it is difficult to analyze the weak immune responses against small numbers of parasites. Recently, real-time quantitative polymerase chain reaction (PCR) has enabled the analysis the very low levels of gene expression. In this report, the various cytokines produced by CD4+ T cells were measured every 2 up to 11 days post-infection (DPI) after erythrocytic stage malaria infection.
First, the survival curve after P. berghei infection in C57BL/6 and BALB/c mice was confirmed. As shown previously, infected C57BL/6 mice all died early, from 7 to 9 DPI, showing convulsions, shivering, and piloerection, while most BALB/c mice survived this period without any symptoms (Fig. 1a). Then parasitemia was compared between C57BL/6 and BALB/c mice. Parasitemia was higher in C57BL/6 mice than in BALB/c mice from 2 to 9 DPI and significantly (p < 0.05) higher from 3 to 9 DPI, which was confirmed in three independent experiments (Fig. 1b). The body weights of the mice were similar in both strains (data not shown). Infection efficiency of inoculated parasites and doubling time were estimated by linear extrapolation from the parasitemia between 2 and 4 DPI. The infection efficiency was 60% for C57BL/6 mice and 80% for BALB/c mice, and the doubling times were 6.0 h and 7.2 h, respectively. To our knowledge, this is the first report of such a difference in the increase of parasitemia between C57BL/6 and BALB/c mice. It was reported that Th1 cytokines suppress the proliferation of malaria parasites in vitro (Cruz Cubas et al. 1994; Ferrante et al. 1990). However, the estimated doubling time indicated that proliferation is accelerated in Th1-biased C57BL/6 mice. Parasitemia is a function of parasite growth, elimination by immune response, and possibly redistribution in the body. Further studies focused on early immune responses may provide further information about this phenomenon.
Next, the numbers of splenic CD4+ and CD4+CD25+ T cells were compared between C57BL/6 and BALB/c mice in the early infection phase. The total number of the splenic CD4+ T cells started to increase at 5 DPI in both strains and remained generally higher in BALB/c mice but decreased to the original level at 7 DPI in CL57B/6 mice. The peak level was lower in the CL57B/6 mice (Fig. 2a). The total number of the splenic CD4+CD25+ T cells showed a similar profile to total CD4+ T cells in both strains (Fig. 2b). The differences between the two strains were statistically significant (ANOVA, p < 0.05). The percentage of CD25+ cells in splenic CD4+ T cells was constant, i.e., about 10 ~ 15%, after inoculation in both strains (Fig. 2c). Malaria is a systemic disease and antigen presentation and lymphocyte activation occur mostly in the spleen. Thus, the lower T cell proliferation rate may reflect the weaker immunological responses in C57BL/6 mice, suggesting a relationship with early death.
To compare the dynamics of CD4+ T cell subsets in the early phase of infection, the expression levels of various cytokine genes and transcription factors in splenic CD4+ T cells were periodically measured during the course of early infection using real-time quantitative RT-PCR (Fig. 3). IL-2 gene expression decreased abruptly in both strains at 5 DPI and remained suppressed (Fig. 3a). It is reported that IL-2 production was reduced within 7 days after infection, resulting in decreased T cell proliferation (Nie et al. 2007). IFN-γ, a Th1 cytokine, showed an abrupt increase at 5 DPI and then decreased gradually. Contrary to expectations, the IFN-γ level was higher in Th2-biased BALB/c mice than in Th1-biased CL57B/6 mice (Fig. 3b). The expression of T-bet, a transcription factor that promotes the differentiation of Th1 cells, showed a transient increase at 5 DPI (Fig. 3c) in both strains. At 7 DPI, T-bet expression decreased quickly to the original level in BALB/c mice but only to 50% in C57BL/6 mice. This difference was statistically significant and reduced T-bet expression in C57BL/6 mice may be related to the different clinical outcomes.
The expression levels of IL-4 and IL-10 genes, which are both Th2 cytokines, showed abrupt increases at 5 DPI (Fig. 3d, e). This increase was more marked and persistent in BALB/c mice but was transient in C57BL/6 mice. Because IL-4 induces Th2 differentiation, B cell proliferation, and class switching of antibodies while suppressing Th1 differentiation, elevated IL-4 in BALB/c mice with subsequent antibody production may be functional in protection from early death. IL-10 promotes B cell proliferation and antibody production. It was shown that increased levels of CD4+ T cells, which produce IL-10 in primary infection, play a role in anti-disease immunity using MSP-1 TCR transgenic mice (Stephens et al. 2008). IL-4 and IL-10 may protect BALB/c mice from early death by B cell activation. Gene expression levels of the Th2 cytokine IL-6 showed neither an increase nor decrease in C57BL/6 mice but decreased at 5 DPI in BALB/c mice (data not shown). The expression level of GATA-3, a transcription factor that promotes Th2 differentiation, started to decrease at 5 DPI in both strains (Fig. 3f).
The expression level of Foxp3, the master transcription factor of Treg cells, decreased at 5 DPI in CL57B/6 mice but decreased at 7 DPI in BALB/c mice (Fig. 3i). However, TGF-β, which is produced by Treg cells, decreased at 5 DPI and remained low in both mice strain (Fig. 3g). This paradox should be elucidated in further studies. Total CD4+CD25+ T cell numbers remained elevated in BALB/c mice even after Foxp3 levels decreased at 7 DPI, suggesting that a fraction of the increased CD4+CD25+ T cells represented activated T cells rather than Treg cells (Fig. 2b). The present findings showed that C57BL/6 mice started to die at 7 DPI (Fig. 1a), when Foxp3 expression decreased (Fig. 3i), suggesting that Treg cells may have no correlation with early death in the system of P. berghei ANKA infection in C57BL/6 mice.
The levels of IL-17 gene expression, which is produced by Th17 cells, decreased remarkably in both strains at 5 DPI and remained low thereafter, suggesting that these cells are not involved in either protection or early death (Fig. 3h), or the reduction in IL-17 level may be related to the progress of infection.
Overall, the levels of cytokine production in C57BL/c mice were lower than that those of BALB/c mice (Fig. 3), suggesting that early death in C57BL/6 mice is caused by lower immune response rather than cytokine storm. Furthermore, it is suggested that elevated IL-4 and IL-10 levels in BALB/c may protect from early death by promoting antibody production (Fig. 3d, e).
In conclusion, the immune responses elucidated in this study indicated that 5 DPI is the turning point in both mouse strains, while early death in C57BL/6 mice started from 7 DPI in this model. To date, studies on vaccine development using mouse models have usually focused on the late infection phase, but the present study showed that the early phase is very important. The development of a malaria vaccine to control parasitemia or CD4+ T cell responses up to 5 DPI should be pursued using this infection model to protect hosts from early death.
References
Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6:147
Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353–360
Cockburn IA, Zavala F (2007) T cell memory in malaria. Curr Opin Immunol 19:424–429
Cruz Cubas AB, Gentilini M, Monjour L (1994) Cytokines and T-cell response in malaria. Biomed Pharmacothr 48:27–33
Doolan DL, Martinez-Alier N (2006) Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 6(2):169–185
Ferrante A, Kumaratilake L, Rzepczyk CM, Dayer JM (1990) Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Immunol Lett 25(1–3):179–187
Griffith JW, O’Connor C, Bernard K, Town T, Goldstein DR, Bucala R (2007) Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis 196:1553–1564
Haque A, Echchannaoui H, Seguin R, Schwartzman J, Kasper LH, Haque S (2001) Cerebral malaria in mice: interleukin-2 treatment induces accumulation of γδ T cells in the brain and alters resistant mice to susceptible-like phenotype. Am J Pathol 158(1):163–172
Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno K, Kishihara K, Tsukumo S, Yasumoto K (2004) Escape of malaria parasites from host immunity requires CD4+CD25+ regulatory T cells. Nat Med 10:29–30
Hoffman SL, Isenbarger D, Long GW, Sedgah M, Szarfman A, Mellouk S, Ballou WR (1990) T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull World Health Organ 68(Suppl):132–137
de Kossodo S, Grau GE (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151(9):4811–4820
Langhorne J (1994) The immune response to the blood stages of Plasmodium in animal models. Immunol Lett 41:99–102
Langhorne J, Albano FR, Hensmann M, Sannni L, Cadman E, Voisine C, Sponaas AM (2004) Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 201:35–47
Long TTA, Nakazawa S, Onizuka S, Huaman MC, Kanbara H (2003) Influence of CD4+CD25+ T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int J Parasitol 33:175–183
Mackintosh CL, Beeson JG, Marsh K (2004) Clinical features and pathogenesis of severe malaria. Trends Parasitol 20(12):597–603
Nie CQ, Bernard NJ, Schofield BL, Hansen DS (2007) CD4+CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific Th1 responses involved in cerebral malaria pathogenesis. Infect Immun 75:2275–2282
Perlmann P, Perlmann H, Berzins K, Troye-Blomberg M (1998) Selected problems of malaria blood stage immunity. Tokai J Exp Clin Med 23:55–62
Riley EM, Wahl S, Perkins DJ, Schofield L (2006) Regulating immunity to malaria. Parasite Immunol 28:35–49
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164
Seixas E, Ostler D (2005) Plasmodium chabaudi chabaudi (AS): differential cellular responses to infection in resistant and susceptible mice. Exp Parasitol 110:394–405
Stephens R, Langhorne J (2006) Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria. Parasite Immunol 28:25–30
Stephens R, Albano FR, Quin S, Pascal BJ, Harrison V, Stockinger B, Kioussis D, Weltzien H, Langhorne J (2008) Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106:1676–1684
Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214–217
Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, Edele F, de Souza JB, Sinden RE, Gilbert SC, Riley EM, Hill AV (2005) Upregulation of TGF-b, FOXP3 and CD4+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23(3):287–296
Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineage. Annu Rev Immunol 25:821–852
WHO (1992) World malaria situation 1990. World Health Stat Q 45:257–266
Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC (1996) Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 157(4):1620–1624
Acknowledgments
This work was supported in part by a Grant-in Aid for Young Researchers from the Ministry of Education and Science of Japan (50313846 to AS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shibui, A., Hozumi, N., Shiraishi, C. et al. CD4+ T cell response in early erythrocytic stage malaria: Plasmodium berghei infection in BALB/c and C57BL/6 mice. Parasitol Res 105, 281–286 (2009). https://doi.org/10.1007/s00436-009-1435-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-009-1435-8